| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 05/06/2010 | US20100113755 Isolated modified human chorionic gonadotropin proteins |
| 05/06/2010 | US20100113600 Anti-cancer agents and androgen inhibition activity compound |
| 05/06/2010 | US20100113485 Piperidinylamino-thieno[2,3-D] Pyrimidine Compounds |
| 05/06/2010 | US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1 |
| 05/06/2010 | US20100113408 21-substituted progesterone derivatives as new antiprogestational agents |
| 05/06/2010 | US20100112090 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 05/06/2010 | US20100111901 Triazole inhibitors of aromatase |
| 05/06/2010 | CA2739712A1 Peptide having anti-diabetic activity and use thereof |
| 05/05/2010 | EP1414486B1 Use of glp-2 in combination with another therapeutic agent in bone-related disorders |
| 05/05/2010 | EP1115398B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 05/05/2010 | CN1980949B New 2-substituted d-homo-estra-1,3,5(10)-trienes as inhibitors of 17beta-hydroxy steroid dehydrogenase type 1 |
| 05/05/2010 | CN1787820B Composition for improving cognition and memory |
| 05/05/2010 | CN1649569B Controlled release dosage forms |
| 05/05/2010 | CN101701218A Immune regulatory oligodeoxynucleotide for inhibiting differentiation of Th1 and Th17 and application thereof |
| 05/05/2010 | CN101700241A Raloxifene emplastrum preparation and preparation method thereof |
| 05/05/2010 | CN101700233A Method for preparing gonadorelin freeze-dried powder injection |
| 05/04/2010 | US7709526 Use of cyclolignans and new cyclolignans |
| 05/04/2010 | US7709519 2-(1,3-Dihydro-2H-benzimidazol-2-ylidene)-1-[3-(1,2-dihydroxyethyl)phenyl]-3-(3,4,5-trifluorophenyl)propane-1,3-dione; GnRH receptor antagonism; prostate cancer, breast cancer, endometriosis, uterine leiomyoma, benign prostatic hypertrophy; good availability by oral administration |
| 05/04/2010 | US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis |
| 05/04/2010 | US7709500 Chemical compounds |
| 05/04/2010 | US7709445 Colloidal suspension of nanoparticles based on an amphiphilic copolymer |
| 05/04/2010 | CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators |
| 05/04/2010 | CA2437767C Heterocyclic inhibitors of erk2 and uses thereof |
| 04/29/2010 | WO2010046855A1 Bridged tetrahydronaphthalene derivatives |
| 04/29/2010 | WO2010046360A1 Process for the preparation of substantially optically pure repaglinide and precursors thereof |
| 04/29/2010 | WO2010009227A3 Recombinant pokeweed antiviral proteins, compositions and methods related thereto |
| 04/29/2010 | US20100105946 Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol) |
| 04/29/2010 | US20100105915 Chemokine receptor binding heterocyclic compounds |
| 04/29/2010 | US20100105744 Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereof |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | CA2740430A1 Bridged tetrahydronaphthalene derivatives |
| 04/28/2010 | EP2178899A1 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative |
| 04/28/2010 | EP2178818A2 Treatments using vitamin k analogues and derivatives |
| 04/28/2010 | EP1347751B1 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 04/28/2010 | EP1062240B1 N-terminally modified glp-1 derivatives |
| 04/28/2010 | EP1060191B1 Derivatives of glp-1 analogs |
| 04/28/2010 | CN1468307B Anti-dual integrin antibodies, compositions, methods and uses |
| 04/27/2010 | US7705182 Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 04/27/2010 | US7705125 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/27/2010 | US7705124 Leucine-based motif and clostridial neurotoxins |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704526 Sustained release composition for oral administration of drugs |
| 04/27/2010 | US7704525 Lipid microparticles by cryogenic micronization |
| 04/27/2010 | CA2431645C Methods of treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2338968C Glucocorticoid-selective agents |
| 04/22/2010 | WO2010023572A4 Herbal extract as sensitivity enhancer toward insulin and antidiabetes |
| 04/22/2010 | WO2010016931A3 Polymorphs of fluticasone furoate and process for preparation thereof |
| 04/22/2010 | US20100099655 Implants and methods for treating inflammation-mediated conditions of the eye |
| 04/22/2010 | US20100099610 Transglutaminase Variants with Improved Specificity |
| 04/22/2010 | DE202008016399U1 Progesteron in homöopathischer Dosierung Progesterone in homeopathic doses |
| 04/22/2010 | CA2740685A1 Combination of an insulin and a glp-1 agonist |
| 04/21/2010 | EP2177221A1 Process for the preparation of substantially optically pure Repaglinide and precursors thereof |
| 04/21/2010 | EP2177212A1 Methods of using lamellar bodies for therapeutic purposes |
| 04/21/2010 | EP2176282A2 8-beta-substituted estratrienes as selectively active estrogens |
| 04/21/2010 | EP2176220A2 Pyrrolidin-2-one derivatives as androgen receptor modulator |
| 04/21/2010 | EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/21/2010 | CN101696247A Method for preparing moisturizing agent N-maleylation-O-carboxymethyl chitosan |
| 04/21/2010 | CN101696240A Long lasting growth hormone releasing factor derivatives |
| 04/21/2010 | CN101695497A Injection medicament for treating chronic lymphoid thyreoitis |
| 04/21/2010 | CN101156847B Usage of purplish plastocyanin as insulin sensitization agent |
| 04/21/2010 | CN101028311B Use of selaginella tamariscina |
| 04/20/2010 | US7700657 Vitamin D analogs |
| 04/20/2010 | US7700632 3-(3-Chloro-biphenyl-4-yloxymethyl)-benzoic acid; antidiabetic; type 2 diabetes, insulin resistance, impaired glucose tolerance, obesity |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | CA2448356C N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 04/20/2010 | CA2388240C Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 04/20/2010 | CA2319680C Compounds and compositions for delivering active agents |
| 04/20/2010 | CA2279331C Compounds and compositions for delivering active agents |
| 04/15/2010 | WO2010042642A1 Calcium receptor modulating agents |
| 04/15/2010 | WO2010042626A1 1-phenylpyrrole compounds |
| 04/15/2010 | WO2010041748A1 Fluorene compound and use thereof for medical purposes |
| 04/15/2010 | US20100093853 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| 04/15/2010 | US20100093802 Ccr9 inhibitors and methods of use thereof |
| 04/15/2010 | US20100093762 Methods for treating or preventing symptoms of hormonal variations |
| 04/15/2010 | US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 04/15/2010 | US20100092477 Methods and compositions for treating prostate cancer |
| 04/15/2010 | US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/15/2010 | CA2736930A1 1-phenylpyrrole compounds |
| 04/14/2010 | EP2174949A2 Leucine-based motif and clostridial neurotoxins |
| 04/14/2010 | EP2173891A2 Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives |
| 04/14/2010 | EP1641745B1 Propionamide derivatives useful as androgen receptor modulators |
| 04/14/2010 | EP1335901B1 Pharmaceutically active sulfanilide derivatives |
| 04/14/2010 | CN101693736A Novel peptides |
| 04/14/2010 | CN101693697A Pyrizdazine derivatives and their use as therapeutic agents |
| 04/13/2010 | US7696331 parenterally administering a dose of samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and carboplatin or taxoids; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 04/13/2010 | US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 04/13/2010 | US7696216 Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives |
| 04/13/2010 | US7696209 1(R)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-[4-(tetrahydropyran-4-yl)-piperazin-1-yl]-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl); calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 04/13/2010 | US7696190 16Alpha-methyl or ethyl substituted estrogens |
| 04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
| 04/13/2010 | US7696149 Peptides present in form of acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate or phosphate salts and administration forms also contain one of above acids as free acids; for treating sex hormone-dependent diseases |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2422377C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2394165C Drospirenone for hormone replacement therapy |
| 04/13/2010 | CA2363639C Covalently bridged insulin dimers |
| 04/13/2010 | CA2203528C Methods and kits using macrophage stimulating protein |
| 04/08/2010 | US20100087404 Method of treating and preventing hyperparathyroidism with active vitamin d analogs |
| 04/08/2010 | US20100087396 Novel Compounds Having Selective Inhibiting Effect at GSK3 |